The global choline chloride market is valued at US$0.50 billion in 2025 and is expected to grow at a compound annual growth rate of 5.12% to reach a market size of US$0.64 billion in 2030.
Choline chloride is an essential organic compound mainly related to metabolism and acts as a methyl donor. It helps in building and maintaining cell structure and cell functioning. It plays a vital role in the nutrition of growing animals by preventing diseases such as pyrosis, fatty liver syndrome, and others. Choline chloride is also termed an essential factor in human nutrition. It also has applications in the oil and gas industry as a clay stabilizer.
The choline chloride market growth worldwide is predicted to be driven by the increasing demand for meat consumption, such as poultry meat and eggs, and rising awareness towards nutritional feed supplements among ranchers, farmers, and animal feed retailers.
However, the threat due to the spread of diseases such as swine flu due to the consumption of meat and the increasing vegan population is expected to restrict meat consumption. This is projected to hinder the choline chloride market.
The growing awareness of the nutritional animal feed supplement among end-users is one of the prominent factors contributing to the global choline chloride market. The introduction of various advanced technologies in the last few years has led many farmers toward practicing animal husbandry as an economic source. The increasing awareness of the consumption of dairy products among millennials has led to the growth in dairy farming. Dairy is India's largest agricultural commodity, contributing 5% of the national economy. To sustain and increase productivity, it is essential to use nutritional supplements for dairy farming.
Likewise, due to the health benefits of meat, the consumption of meat and eggs is experiencing growth. Hence, poultry farmers are expected to use nutritional supplements for livestock to provide disinfected meat products. Following this, beef and veal consumption in the European Union was 6,620.3 thousand tonnes in 2023. Moreover, the increasing demand from the population for meat consumption is predicted to drive the demand for nutritional animal feed, paving the way for the global choline chloride market’s growth.
The rising threat of livestock diseases, which can affect the productivity and economy of ranchers, farmers, retailers, and other livestock-dependent businesses, is propelling the demand for nutritional animal feed and supplements. The growing urbanization and awareness about diseases and nutrition among pet lovers also contributed to boosting the demand for nutritional animal feed. This is expected to increase the demand for choline chloride supplements, leading to market growth during the forecast period.
Choline chloride is also an essential nutritional factor for the human body. The rising research on its benefits for humans has paved the way for increasing awareness among the global population. For instance, Harvard T.H. Chan School of Public Health published a report stating the key benefits of choline for the human body. According to the report, Choline helps in the contraction of muscles, improves memory and thinking by improving brain function, and activates pain responses. Additionally, choline is also termed as food for beneficial gut bacteria.
By application, the pet food industry is anticipated to be one of the fastest-growing segments in the choline chloride market.
Chlorine chloride is extensively utilized in animal nutrition as a necessary component that promotes healthy growth and development. It works mainly by supporting liver function and fat metabolism. Within the pet food industry, the growing need for premium, nutrient-dense food due to increased pet ownership and pet owners' concern for their animals' well-being has increased the need for choline chloride. In 2022, the two biggest pet food businesses in India were Mars Inc. and Indian Broiler Group, with a combined market share of 66.9%. Mars International India PVT LTD topped the retail sales charts in 2022, with sales of US$281.5 million.
Trends like premiumization in pet food, where owners look for useful ingredients that improve their pets' general well-being, also contribute to this rise. With the increasing number of pets worldwide and customers' increased willingness to spend on their pets' diets, the market for choline chloride as an essential supplement is expected to rise substantially.
Asia Pacific’s choline chloride market is anticipated to grow significantly.
Owing to the increasing demand for nutritional animal feed supplements to fulfill the demand of rising livestock businesses, the Asia-Pacific region is predicted to hold a significant market share during the forecast period. Countries like China, India, Indonesia, and a few others are predicted to boost the market owing to the increasing demand for meat and egg consumption, urbanization, an increasing number of pet owners, and rising per capita income. India imported pet food worth US$144.1 million in 2022, a 33.6% rise in yearly growth from US$45.3 million in 2018. In 2022, Canada accounted for 1.6% of India's pet food market share, or US$2.3 million, making it the eighth-largest supplier. This is a notable increase in yearly growth of 31.1% from US$0.8 million in 2018.
North America is also expected to grow at a steady pace during the forecast period owing to the growing demand for organic-based nutritional animal feed in countries like the United States and Canada. For instance, the United States is home to over 5,650 animal food production plants that produce over 284 million tonnes of pet food and finished feed annually.
In July 2024, Expana gathered input from market players and intends to introduce weekly Expana Benchmark Prices (EBP) for vitamin B12 and choline chloride in all territories.
In June 2024, Kemin Industries entered the U.S. dairy market with CholiGEMTM, an advanced rumen-protected choline supplement. This supplement addresses fatty liver and ketosis in lactating dairy cows. Kemin Industries is a global ingredient manufacturer that aims to sustainably transform the quality of life every day for 80 percent of the world through its products and services.
In April 2024, the U.S. Food and Drug Administration (FDA) and Protara Therapeutics, Inc., a clinical-stage company creating transformative therapies for cancer and rare disease treatment, have aligned on a registrational path forward for intravenous (IV) choline chloride. This is an experimental treatment that replaces phospholipid substrate.
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 0.50 billion |
| Total Market Size in 2030 | USD 0.64 billion |
| Forecast Unit | Billion |
| Growth Rate | 5.12% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Segmentation | Form, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|